Q3 2023 Ocugen Inc Earnings Call Transcript
Good morning, and welcome to Ocugen's third-quarter 2023 financial results and business update. Please note that this call is being recorded at this time. (Operator Instructions)
I will now turn the call over to Tiffany Hamilton, Ocugen's, Head of Corporate Communications. You may begin.
Thank you, operator, and good morning, everyone. Joining me on today's call and webcast is Dr. Shankar Musunuri, Ocugen's Chairman, CEO, and Co-founder, who will provide a business update and an overview of our clinical and operational progress. Michael Breininger, our Corporate Controller, is also on the call to provide a financial update for the quarter ended September 30, 2023. Dr. Arun Upadhyay, Chief Scientific Officer, Head of Research, Development, and Medical will be available to answer questions following the presentation.
This morning, we issued a press release detailing associated business and operational highlights for the third quarter of 2023. We encourage listeners to review the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |